As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Epigenetics Market: By Product: Kits, Reagents, Enzymes, Instruments; By Application: Oncology, Non-Oncology; By End Use: Academic and Research Institutes, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Epigenetics Market Outlook

The global epigenetics market stood at a value of around USD 877 million in 2020. The market is further expected to grow at a CAGR of 13.6% in the forecast period of 2022-2027 to attain a value of USD 1,908 million by 2026.

 

Kits Segment to Possess a Substantial Share of the Global Epigenetics Industry

Based on product, the kits segment holds a significant share in the global epigenetics industry. This growth can be attributed to the important role of kits in the entire epigenetic analysis process. Furthermore, this number is further expected to rise in the forecast period due to the increasing chronic illnesses and the growing geriatric population rates, which is very susceptible to acquiring various diseases, including cardiovascular diseases or cancer.

 

Global Epigenetics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Meanwhile, the oncology segment is estimated to observe a healthy growth in terms of application due to the high usage of epigenetic research in the oncology field.

 

North America to Account for a Significant Market Share of the Global Epigenetics Industry

North America is predicted to occupy a considerable share of the global epigenetics industry. This surge can be attributed to the increased utilisation of epigenetic research in the region and the increased investments in the development of the healthcare sector. Another factor influencing the market growth is the rising geriatric population in the region, who are susceptible to chronic diseases such as Parkinson’s disease and cancer.

 

Epigenetics: Industry Definition and Segmentation

Epigenetics is an emerging scientific area of study that analyses how environmental influences impact the expression of genes. Based on different environmental experiences, genes are activated and deactivated by cells without any change in the underlying DNA structure of the organism and predict which proteins are transcribed. These external environmental stimuli can affect the genes, which could influence diseases. In addition, research has indicated that many human diseases occur due to the interaction between genetic variants and environmental exposure, such as autism, Parkinson’s disease, and breast cancer, among others.

By product, the market is divided into:

  • Kits
  • Reagents
  • Enzymes
  • Instruments

Kits are further divided by type into ChIP sequencing kits, bisulfite conversion kits, whole genome amplification kits, 5-hmC & 5-mC analysis kits, and RNA sequencing kits, among others. At the same time, reagents are further segmented by type into antibodies, magnetic beads, histones, buffers, primers, and others. Meanwhile, enzymes are categorised by type into DNA polymerases, DNA ligases, methyltransferases, acetylases, and reverse transcriptase, among others. And instruments are segregated by type into next-generation sequencers, qPCRs, mass spectrometers, sonicators, and others.

On the basis of application, the industry can be categorised into:

  • Oncology 
  • Non-Oncology

Oncology is further divided by type into solid tumours and liquid tumours, whereas non-oncology is segmented by type into metabolic diseases, infectious diseases, inflammatory diseases, cardiovascular diseases, and others.

Based on end use, the market can be segmented into:

  • Academics and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organisations

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Increasing Prevalence of Cardiovascular Diseases to Augment the Growth of the Global Epigenetics Industry

According to WHO reports, cardiovascular diseases are the leading cause of death globally, claiming more than 17.9 million lives every year. Cardiovascular diseases are illnesses of heart and blood vessels that are adversely affected by high-risk behaviours such as unhealthy diet, physical inactivity, and substance abuse. In this regard, epigenetic research has found epigenetic biomarkers, a promising tool for the diagnosis and prognosis of many cardiovascular diseases. Some of their promising features include easy accessibility and feasibility in their detection methods, making them applicable for use in clinical interventions. This is significantly contributing to the growth of the market.

In a 2017 research by the American Diabetes Association, the researchers concluded that diabetes is a complication developed from the interaction of DNA structure variation and the environmental stimuli that causes changes in the cellular phenotype.

 

Key Industry Players in the Global Epigenetics Market

The report gives a detailed analysis of the following key players in the global epigenetics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Abcam Plc
  • Active Motif, Inc.
  • Agilent Technologies, Inc.
  • Diagenode S.A.
  • QIAGEN GmbH
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, End Use, Region
Breakup by Product Kits, Reagents, Enzymes, Instruments
Breakup by Application Oncology, Non-Oncology
Breakup by End Use Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organisations
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., QIAGEN GmbH, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Epigenetics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Epigenetics Historical Market (2017-2021) 
    8.3    Global Epigenetics Market Forecast (2022-2027)
    8.4    Global Epigenetics Market by Product
        8.4.1    Kits
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    ChIP Sequencing Kits
                8.4.1.4.2    Bisulfite Conversion Kits
                8.4.1.4.3    Whole Genome Amplification Kits
                8.4.1.4.4    5-hmC & 5-mC Analysis Kits
                8.4.1.4.5    RNA Sequencing Kits
                8.4.1.4.6    Others
        8.4.2    Reagents
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Antibodies
                8.4.2.4.2    Magnetic Beads 
                8.4.2.4.3    Histones 
                8.4.2.4.4    Buffers
                8.4.2.4.5    Primers
                8.4.2.4.6    Others
        8.4.3    Enzymes
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
            8.4.3.4    Breakup by Type
                8.4.3.4.1    DNA Polymerases
                8.4.3.4.2    DNA Ligases 
                8.4.3.4.3    Methyltransferases
                8.4.3.4.4    Acetylases
                8.4.3.4.5    Reverse Transcriptase
                8.4.3.4.6    Others
        8.4.4    Instruments
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
            8.4.4.4    Breakup by Type
                8.4.4.4.1    Next generation sequencers
                8.4.4.4.2    qPCRs
                8.4.4.4.3    Mass Spectrometers
                8.4.4.4.4    Sonicators
                8.4.4.4.5    Others
    8.5    Global Epigenetics Market by Application
        8.5.1    Oncology
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
            8.5.1.4    Breakup by Type
                8.5.1.4.1    Solid Tumors
                8.5.1.4.2    Liquid Tumors
        8.5.2    Non-Oncology
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
            8.5.2.4    Breakup by Type
                8.5.2.4.1    Metabolic Diseases
                8.5.2.4.2    Infectious Diseases
                8.5.2.4.3    Inflammatory Diseases
                8.5.2.4.4    Cardiovascular Diseases
                8.5.2.4.5    Others
    8.6    Global Epigenetics Market by End Use
        8.6.1     Academic and Research Institutes
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Pharmaceutical and Biotechnology Companies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Contract Research Organisations
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
    8.7    Global Epigenetics Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyers Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Abcam Plc
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Active Motif, Inc.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Agilent Technologies, Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Diagenode S.A.
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    QIAGEN GmbH
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Figures and Tables

1.    Global Epigenetics Market: Key Industry Highlights, 2016 and 2026
2.    Global Epigenetics Historical Market: Breakup by Product (USD Million), 2017-2021
3.    Global Epigenetics Market Forecast: Breakup by Product (USD Million), 2022-2027
4.    Global Epigenetics Historical Market: Breakup by Application (USD Million), 2017-2021
5.    Global Epigenetics Market Forecast: Breakup by Application (USD Million), 2022-2027
6.    Global Epigenetics Historical Market: Breakup by End Use (USD Million), 2017-2021
7.    Global Epigenetics Market Forecast: Breakup by End Use (USD Million), 2022-2027
8.    Global Epigenetics Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Epigenetics Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Epigenetics Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Epigenetics Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Global Epigenetics Market Structure

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER